Filter
189
Filtered Results: 189
Text search:
DTG
Featured
Recommendations
16
New Publications
46
Language
Document type
No document type
118
Guidelines
35
Studies & Reports
22
Manuals
4
Fact sheets
3
Infographics
2
Strategic & Response Plan
2
Training Material
1
Brochures
1
Situation Updates
1
Countries / Regions
Kenya
7
Malawi
6
Zambia
6
South Africa
5
Germany
4
Russia
4
Namibia
4
Mozambique
3
Global
3
Congo, Democratic Republic of
3
Botswana
3
Myanmar / Burma
3
Nepal
2
Ukraine
2
Lesotho
2
Nigeria
2
Zimbabwe
2
Philippines
2
Africa
2
Western and Central Europe
2
Argentina
2
Brazil
2
Ethiopia
2
Tajikistan
1
Ghana
1
Sierra Leone
1
Rwanda
1
Syria
1
Albania
1
Senegal
1
Burkina Faso
1
Guinea
1
Armenia
1
Haiti
1
Cambodia
1
Asia
1
Venezuela
1
Latin America and the Carribbean
1
Middle East and North Africa
1
South–East Asia Region
1
Western Pacific Region
1
Paraguay
1
Bangladesh
1
Uganda
1
Eastern Europe
1
Moldova
1
Yemen
1
Central African Republic
1
Chad
1
South Sudan
1
Indonesia
1
Liberia
1
India
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Statistics
29
Policies & Guidelines HIV & TB
28
HIV & STI
15
Guidelines
5
Drugs & Medical Equipment
4
Women & Child Health
4
COVID-19
3
Studies & Reports
3
Capacity Building
3
TB
3
Hepatitis
2
Humanitarian Crisis
2
Reproductive Health
2
Pharmacy & Technologies
2
Communicable Diseases
1
Zika
1
Paediatrics
1
Emergency Health Kits
1
Buruli Ulcer
1
Humanitarian Aid
1
Annual Report MEDBOX
1
x MEDBOX Issue Brief & Annual Reports x
1
MPOX - Monkeypox
1
Public Health
1
Pediatrics
1
Countries
1
Chagas
1
Policies
1
General Guidelines
1
Maternal Health
1
Primary Health Care
1
Neurology & Psychology
1
Disease Prevention & Control
1
Toolboxes
Antiretroviral Treatment ART
25
Clinical Aspects, Treatment & Prevention
18
ART Drug Resistance
15
Treatment Guidelines HIV
14
Treatment & Prevention
11
Children & Adolescents
11
Clinical Aspects
6
Drug resistance
6
Travel Advice
5
Co-Morbidities (except TB)
5
Reports & Studies Children HIV
5
Reports & Studies
5
General Reports
4
For General Public
4
Essential Medicines
4
Context & Facts
3
Universal Health Coverage UHC and 90-90-90 Strategy
3
HIV and COVID-19
3
Access to treatment and laboratory
3
Policies and guidelines
3
Prevention of mother-to-child transmission (PMTCT)
3
HIV and coinfection
3
TB/HIV Coinfection
3
HIV service delivery
3
Eastern Europe and central Asia
3
Childhood TB
2
HIV testing & services
2
Opportunistic Infections
2
Policies
2
Global
2
Health & Refugee
2
Laboratory
2
Country specific documents
2
COVID-19
2
Essential Medicines & Devices Lists
2
Rational use of Medicine
2
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
2
General Aspects
2
HIV / AIDS
2
Lobby and Advocacy
2
Vaccination
2
Behaviour Change/Life Skill Education
1
HIV support organizations
1
Posttraumatic stress disorder Adults
1
Ebola Prevention & Control
1
Vaccination
1
Adults
1
Ukraine
1
Pediatrics
1
Prevention Guidelines
1
Schizophrenia
1
Children
1
Social Worker
1
HIV
1
Others
1
Ebola
1
Children
1
Microcephaly
1
International
1
General
1
Infection Control General
1
COVID-19
1
For Pregnant Women
1
Training, others
1
Global Impact: Socio-economic, health services, TB & HIV
1
Guidelines
1
Gender Aspects
1
TB/COVID-19
1
Brazil
1
Mental Disorders
1
Situation Reports & Updates
1
General
1
MPOX - Monkeypox
1
Chagas
1
Clinical Aspects & Diagnostics
1
Overview, Studies & Reports
1
Detection & Diagnosis
1
Asia and Pacific
1
Drug resistant TB
1
General
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
Bipolar Affective Disorders
1
Protection
1
Assessment & Response
1
TB/HIV Global
1
Mental Health
1
Tuberculosis
1
Assessment & Response
1
Roadmaps, Action Plans & Policies
1
Testing Guidelines
1
Travel Medicine
1
Public Health Administration
1
Epidemiology
1
Refugees & Migrants
1
HIV in Key Populations
1
Eastern Europe & Central Asia
1
Depression
1
Kenya
1
Pregnant women
1
Volunteers
1
Preparedness & Prevention
1
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
A Global Analysis of Antimicrobial Resistance and Its Drivers.
Since the first State of the World’s Antibiotics report in 2015, antimicrobial resistance has leveled off in some high-income countries but continues to rise in many low- and middle-income countries (LMICs), where access to antibiotic...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
July 2021. This publication brings together important clinical and programmatic updates produced by WHO since 2016 and provides comprehensive, evidence-informed recommendations and good practice statements within a public health, rights-based and person-centred approach.
These guidelines bring in...
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
Guia rápido para profissionais de saúde
Milestones in the treatment, care and support, Dec 2021
Desde el 2010, los Estados miembros de la Organización Panamericana
de la Salud (OPS) han asumido el compromiso de impulsar la eliminación de la transmisión materno infantil (ETMI) de la infección por el VIH y la sífilis. Estos compromisos se renovaron y ampliaron en el año 2016 mediante la...
The highly complex and largely neglected Chagas disease (CD) has become a global health problem due to population movements between Latin America and non-endemic countries, as well as non-vectorial transmission routes. Data on CD testing and treatment from routine patient care in Germany of almost t...
A medida que el tratamiento antirretrovírico con dolutegravir se extiende a más personas que viven con el VIH en el
mundo, adquiere más importancia estimar la frecuencia con que surge la farmacorresistencia adquirida a este
antirretrovírico en las poblaciones tratadas con esquemas que lo conti...
This policy brief describes key HIV viral load thresholds and the available viral load testing approaches for monitoring how well antiretroviral therapy is working for people living with HIV. It provides clarification for and elaborates upon the current treatment monitoring algorithm from the Consol...
Les médicaments ont été classés à la fois par classe pharmaco-thérapeutique et par ordre alphabétique. La présence d’une marque astérisque renvoie à davantage de précision pour le (les) médicament(s) concerné(s).
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Les médicaments essentiels sont ceux qui répondent aux besoins de santé prioritaires d'une population. Conformément aux recommandations de l'Organisation mondiale de la Santé (OMS), des listes nationales de médicaments essentiels sont régulièrement révisées, puis mises à la disposition de...
This status report shows how far we have come—and how much further we must go—if we hope to meet the global commitments to end AIDS in children. It offers a snapshot of global progress and permits an early assessment of the impact of the Global Alliance’s work.
PEPFAR Malawi’s Country Operational Plan (COP) 2021 reflects a culmination of strong interagency collaboration between the PEPFAR Malawi team, Government of Malawi (GoM), and civil society organizations (CSOs) to mitigate the devastating impacts of COVID-19 and sustain progress achieved over the l...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
